GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VivoSim Labs Inc (FRA:4OR) » Definitions » Other Gross PPE

VivoSim Labs (FRA:4OR) Other Gross PPE : €0.46 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is VivoSim Labs Other Gross PPE?

VivoSim Labs's Other Gross PPE for the quarter that ended in Dec. 2024 was €0.46 Mil.

VivoSim Labs's quarterly Other Gross PPE declined from Jun. 2024 (€0.56 Mil) to Sep. 2024 (€0.49 Mil) and declined from Sep. 2024 (€0.49 Mil) to Dec. 2024 (€0.46 Mil).

VivoSim Labs's annual Other Gross PPE increased from Mar. 2022 (€1.06 Mil) to Mar. 2023 (€1.47 Mil) and increased from Mar. 2023 (€1.47 Mil) to Mar. 2024 (€1.49 Mil).


VivoSim Labs Other Gross PPE Historical Data

The historical data trend for VivoSim Labs's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VivoSim Labs Other Gross PPE Chart

VivoSim Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.82 1.06 1.47 1.49

VivoSim Labs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 1.49 0.56 0.49 0.46

VivoSim Labs Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


VivoSim Labs Business Description

Traded in Other Exchanges
Address
11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

VivoSim Labs Headlines

No Headlines